Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes

References

Page 1

	Year	Citations
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study Albert Hofman, Alewijn Ott, Monique M.B. Breteler, The Lancet Alzheimer's DiseaseAgingAtherosclerosisDementiaVascular Dementia	1997	1.4K
Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience Nathan A. Johnson, Geon‐Ho Jahng, Michael W. Weiner, Radiology	2005	590
Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 Diabetes Sanne Manschot, Augustina M.A. Brands, Jeroen van der Grond, Diabetes	2006	476
Diabetes, Alzheimer disease, and vascular dementia Satu Ahtiluoto, Tuomo Polvikoski, Markku Peltonen, Neurology AgingGeriatric NeurologyAlzheimer's DiseaseNeurologyAging-associated Disease	2010	472
Detecting significant change in neuropsychological test performance: A comparison of four models Nancy Temkin, Robert K. Heaton, Igor Grant, Journal of the International Neuropsychological Society	1999	323
The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm Jobien K. Olijhoek European Heart Journal	2004	298
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus Diabetologia	2009	251
Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral Vasoreactivity David Last, David C. Alsop, Amir Abduljalil, Diabetes Care	2007	238
Reduced neuropsychological test performance in asymptomatic carotid stenosis Ellisiv B. Mathiesen, Knut Waterloo, Oddmund Joakimsen, Neurology	2004	233
Probabilistic segmentation of brain tissue in MR imaging Petronella Anbeek, Koen L. Vincken, Glenda S. van Bochove, NeuroImage EngineeringMedical ImagingBiomedical ImagingNeuroimagingNeuroscience	2005	213

Page 1